_id
6911bc11ccc777a4e85d61f8
Ticker
GHRS
Name
GH Research PLC
Exchange
NASDAQ
Address
Joshua Dawson House, Dublin, Ireland, D02 RY95
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.ghres.com
Description
GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.
Last Close
13.8
Volume
122952
Current Price
13.035
Change
-5.543478260869569
Last Updated
2025-11-30T19:21:28.910Z
Image
-
Ipo Date
2021-06-25T00:00:00.000Z
Market Cap
940365632
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.989
Sentiment Sources
1
Rating
4.625
Target Price
30.375
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
89000
Gross Profit
-89000
Operating Expenses
16446000
Operating Income
-16535000
Interest Expense
21000
Pretax Income
-14020000
Net Income
-14020000
Eps
-0.22602187237196172
Dividends Per Share
-
Shares Outstanding
62029395
Income Tax Expense
-
EBITDA
-13910000
Operating Margin
-
Total Other Income Expense Net
2515000
Cash
249654000
Short Term Investments
38853000
Receivables
-
Inventories
-
Total Current Assets
294790000
Property Plant Equipment
692000
Total Assets
302022000
Payables
3837000
Short Term Debt
365000
Long Term Debt
-
Total Liabilities
10625000
Equity
291397000
Depreciation
89000
Change In Working Capital
-3025353
Cash From Operations
-14441693
Capital Expenditures
41266
Cash From Investing
10438646
Cash From Financing
968648
Net Change In Cash
-4219000
PE
-
PB
2.77474772844264
ROE
-4.81130553849216
ROA
-4.6420459436729775
FCF
-14482959
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
3
Quality Investing Score
3
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
89000
Quarters > 0 > income Statement > gross Profit
-89000
Quarters > 0 > income Statement > operating Expenses
16446000
Quarters > 0 > income Statement > operating Income
-16535000
Quarters > 0 > income Statement > interest Expense
21000
Quarters > 0 > income Statement > pretax Income
-14020000
Quarters > 0 > income Statement > net Income
-14020000
Quarters > 0 > income Statement > eps
-0.22602187237196172
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
62029395
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13910000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2515000
Quarters > 0 > balance Sheet > cash
249654000
Quarters > 0 > balance Sheet > short Term Investments
38853000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
294790000
Quarters > 0 > balance Sheet > property Plant Equipment
692000
Quarters > 0 > balance Sheet > total Assets
302022000
Quarters > 0 > balance Sheet > payables
3837000
Quarters > 0 > balance Sheet > short Term Debt
365000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
10625000
Quarters > 0 > balance Sheet > equity
291397000
Quarters > 0 > cash Flow > net Income
-14020000
Quarters > 0 > cash Flow > depreciation
89000
Quarters > 0 > cash Flow > change In Working Capital
-3025353
Quarters > 0 > cash Flow > cash From Operations
-14441693
Quarters > 0 > cash Flow > capital Expenditures
41266
Quarters > 0 > cash Flow > cash From Investing
10438646
Quarters > 0 > cash Flow > cash From Financing
968648
Quarters > 0 > cash Flow > net Change In Cash
-4219000
Quarters > 0 > ratios > PE
-0.22602187237196172
Quarters > 0 > ratios > PB
2.77474772844264
Quarters > 0 > ratios > ROE
-4.81130553849216
Quarters > 0 > ratios > ROA
-4.6420459436729775
Quarters > 0 > ratios > FCF
-14482959
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
82000
Quarters > 1 > income Statement > gross Profit
-82000
Quarters > 1 > income Statement > operating Expenses
14704000
Quarters > 1 > income Statement > operating Income
-14704000
Quarters > 1 > income Statement > interest Expense
174000
Quarters > 1 > income Statement > pretax Income
-9289000
Quarters > 1 > income Statement > net Income
-9289000
Quarters > 1 > income Statement > eps
-0.14975317246509748
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
62028736
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-9198000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
5415000
Quarters > 1 > balance Sheet > cash
253873000
Quarters > 1 > balance Sheet > short Term Investments
37662000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
293880000
Quarters > 1 > balance Sheet > property Plant Equipment
739000
Quarters > 1 > balance Sheet > total Assets
313428000
Quarters > 1 > balance Sheet > payables
3447000
Quarters > 1 > balance Sheet > short Term Debt
364000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10249000
Quarters > 1 > balance Sheet > equity
303179000
Quarters > 1 > cash Flow > net Income
-9289000
Quarters > 1 > cash Flow > depreciation
82000
Quarters > 1 > cash Flow > change In Working Capital
1156000
Quarters > 1 > cash Flow > cash From Operations
-8967000
Quarters > 1 > cash Flow > capital Expenditures
59000
Quarters > 1 > cash Flow > cash From Investing
15710000
Quarters > 1 > cash Flow > cash From Financing
-1073000
Quarters > 1 > cash Flow > net Change In Cash
8919000
Quarters > 1 > ratios > PE
-0.14975317246509748
Quarters > 1 > ratios > PB
2.666888451244974
Quarters > 1 > ratios > ROE
-3.063866560678675
Quarters > 1 > ratios > ROA
-2.963679058667381
Quarters > 1 > ratios > FCF
-9026000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
76000
Quarters > 2 > income Statement > gross Profit
-76000
Quarters > 2 > income Statement > operating Expenses
12732000
Quarters > 2 > income Statement > operating Income
-12732000
Quarters > 2 > income Statement > interest Expense
178000
Quarters > 2 > income Statement > pretax Income
-10812000
Quarters > 2 > income Statement > net Income
-10812000
Quarters > 2 > income Statement > eps
-0.1863233780779999
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
58028145
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-10726000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1920000
Quarters > 2 > balance Sheet > cash
244954000
Quarters > 2 > balance Sheet > short Term Investments
46393000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
294668000
Quarters > 2 > balance Sheet > property Plant Equipment
705000
Quarters > 2 > balance Sheet > total Assets
320454000
Quarters > 2 > balance Sheet > payables
4774000
Quarters > 2 > balance Sheet > short Term Debt
336000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10240000
Quarters > 2 > balance Sheet > equity
310214000
Quarters > 2 > cash Flow > net Income
-10812000
Quarters > 2 > cash Flow > depreciation
76000
Quarters > 2 > cash Flow > change In Working Capital
213000
Quarters > 2 > cash Flow > cash From Operations
-8573000
Quarters > 2 > cash Flow > capital Expenditures
4000
Quarters > 2 > cash Flow > cash From Investing
11838000
Quarters > 2 > cash Flow > cash From Financing
140858000
Quarters > 2 > cash Flow > net Change In Cash
144163000
Quarters > 2 > ratios > PE
-0.1863233780779999
Quarters > 2 > ratios > PB
2.438306685304338
Quarters > 2 > ratios > ROE
-3.4853359293906787
Quarters > 2 > ratios > ROA
-3.3739631897245785
Quarters > 2 > ratios > FCF
-8577000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
78000
Quarters > 3 > income Statement > gross Profit
-78000
Quarters > 3 > income Statement > operating Expenses
12944000
Quarters > 3 > income Statement > operating Income
-12944000
Quarters > 3 > income Statement > interest Expense
179000
Quarters > 3 > income Statement > pretax Income
-8802000
Quarters > 3 > income Statement > net Income
-8802000
Quarters > 3 > income Statement > eps
-0.16917766335893775
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
52028145
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-8714000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
4142000
Quarters > 3 > balance Sheet > cash
100791000
Quarters > 3 > balance Sheet > short Term Investments
48533000
Quarters > 3 > balance Sheet > receivables
1732000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
154225000
Quarters > 3 > balance Sheet > property Plant Equipment
748000
Quarters > 3 > balance Sheet > total Assets
188273000
Quarters > 3 > balance Sheet > payables
3741000
Quarters > 3 > balance Sheet > short Term Debt
255000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9322000
Quarters > 3 > balance Sheet > equity
178951000
Quarters > 3 > cash Flow > net Income
-8802000
Quarters > 3 > cash Flow > depreciation
78000
Quarters > 3 > cash Flow > change In Working Capital
-624000
Quarters > 3 > cash Flow > cash From Operations
-10446000
Quarters > 3 > cash Flow > capital Expenditures
25000
Quarters > 3 > cash Flow > cash From Investing
21331000
Quarters > 3 > cash Flow > cash From Financing
-59000
Quarters > 3 > cash Flow > net Change In Cash
10732000
Quarters > 3 > ratios > PE
-0.16917766335893775
Quarters > 3 > ratios > PB
3.789790892898056
Quarters > 3 > ratios > ROE
-4.918664885918492
Quarters > 3 > ratios > ROA
-4.675126013820357
Quarters > 3 > ratios > FCF
-10471000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
37
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
315000
Annuals > 0 > income Statement > gross Profit
-315000
Annuals > 0 > income Statement > operating Expenses
50312000
Annuals > 0 > income Statement > operating Income
-50312000
Annuals > 0 > income Statement > interest Expense
717000
Annuals > 0 > income Statement > pretax Income
-38961000
Annuals > 0 > income Statement > net Income
-38961000
Annuals > 0 > income Statement > eps
-0.7488446878127214
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
52028145
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-38598000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
11351000
Annuals > 0 > balance Sheet > cash
100791000
Annuals > 0 > balance Sheet > short Term Investments
48533000
Annuals > 0 > balance Sheet > receivables
1732000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
154225000
Annuals > 0 > balance Sheet > property Plant Equipment
748000
Annuals > 0 > balance Sheet > total Assets
188273000
Annuals > 0 > balance Sheet > payables
3741000
Annuals > 0 > balance Sheet > short Term Debt
255000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9322000
Annuals > 0 > balance Sheet > equity
178951000
Annuals > 0 > cash Flow > net Income
-38961000
Annuals > 0 > cash Flow > depreciation
315000
Annuals > 0 > cash Flow > change In Working Capital
188000
Annuals > 0 > cash Flow > cash From Operations
-42285000
Annuals > 0 > cash Flow > capital Expenditures
49000
Annuals > 0 > cash Flow > cash From Investing
65135000
Annuals > 0 > cash Flow > cash From Financing
-304000
Annuals > 0 > cash Flow > net Change In Cash
22371000
Annuals > 0 > ratios > PE
-0.7488446878127214
Annuals > 0 > ratios > PB
4.4076125766271215
Annuals > 0 > ratios > ROE
-21.771881688283383
Annuals > 0 > ratios > ROA
-20.69388600595943
Annuals > 0 > ratios > FCF
-42334000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
315000
Annuals > 1 > income Statement > gross Profit
-315000
Annuals > 1 > income Statement > operating Expenses
41222000
Annuals > 1 > income Statement > operating Income
-41222000
Annuals > 1 > income Statement > interest Expense
723000
Annuals > 1 > income Statement > pretax Income
-35587000
Annuals > 1 > income Statement > net Income
-35587000
Annuals > 1 > income Statement > eps
-0.6840682358978373
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
52022588
Annuals > 1 > income Statement > income Tax Expense
-1
Annuals > 1 > income Statement > EBITDA
-35209000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5635000
Annuals > 1 > balance Sheet > cash
78420000
Annuals > 1 > balance Sheet > short Term Investments
83140000
Annuals > 1 > balance Sheet > receivables
178000
Annuals > 1 > balance Sheet > inventories
-178000
Annuals > 1 > balance Sheet > total Current Assets
164089000
Annuals > 1 > balance Sheet > property Plant Equipment
1069000
Annuals > 1 > balance Sheet > total Assets
226300000
Annuals > 1 > balance Sheet > payables
3490000
Annuals > 1 > balance Sheet > short Term Debt
343000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7332000
Annuals > 1 > balance Sheet > equity
218968000
Annuals > 1 > cash Flow > net Income
-35587000
Annuals > 1 > cash Flow > depreciation
315000
Annuals > 1 > cash Flow > change In Working Capital
1645000
Annuals > 1 > cash Flow > cash From Operations
-33336000
Annuals > 1 > cash Flow > capital Expenditures
100000
Annuals > 1 > cash Flow > cash From Investing
-54100000
Annuals > 1 > cash Flow > cash From Financing
-204000
Annuals > 1 > cash Flow > net Change In Cash
-87535000
Annuals > 1 > ratios > PE
-0.6840682358978373
Annuals > 1 > ratios > PB
3.6017246085272734
Annuals > 1 > ratios > ROE
-16.252146432355413
Annuals > 1 > ratios > ROA
-15.725585505965533
Annuals > 1 > ratios > FCF
-33436000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
47000
Annuals > 2 > income Statement > gross Profit
-47000
Annuals > 2 > income Statement > operating Expenses
30554000
Annuals > 2 > income Statement > operating Income
-30554000
Annuals > 2 > income Statement > interest Expense
8098000
Annuals > 2 > income Statement > pretax Income
-22456000
Annuals > 2 > income Statement > net Income
-22456000
Annuals > 2 > income Statement > eps
-0.43167307784615355
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
52020849
Annuals > 2 > income Statement > income Tax Expense
-15321000
Annuals > 2 > income Statement > EBITDA
-22409000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
8098000
Annuals > 2 > balance Sheet > cash
165955000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
90000
Annuals > 2 > balance Sheet > inventories
-90000
Annuals > 2 > balance Sheet > total Current Assets
168541000
Annuals > 2 > balance Sheet > property Plant Equipment
97000
Annuals > 2 > balance Sheet > total Assets
254362000
Annuals > 2 > balance Sheet > payables
1868000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4546000
Annuals > 2 > balance Sheet > equity
249816000
Annuals > 2 > cash Flow > net Income
-22456000
Annuals > 2 > cash Flow > depreciation
47000
Annuals > 2 > cash Flow > change In Working Capital
2159000
Annuals > 2 > cash Flow > cash From Operations
-26199000
Annuals > 2 > cash Flow > capital Expenditures
67000
Annuals > 2 > cash Flow > cash From Investing
-84688000
Annuals > 2 > cash Flow > cash From Financing
0
Annuals > 2 > cash Flow > net Change In Cash
-110821000
Annuals > 2 > ratios > PE
-0.43167307784615355
Annuals > 2 > ratios > PB
3.156867738015179
Annuals > 2 > ratios > ROE
-8.989015915713965
Annuals > 2 > ratios > ROA
-8.828362727136915
Annuals > 2 > ratios > FCF
-26266000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
19000
Annuals > 3 > income Statement > gross Profit
-19000
Annuals > 3 > income Statement > operating Expenses
15100000
Annuals > 3 > income Statement > operating Income
-15100000
Annuals > 3 > income Statement > interest Expense
9000
Annuals > 3 > income Statement > pretax Income
-9202000
Annuals > 3 > income Statement > net Income
-9202000
Annuals > 3 > income Statement > eps
-0.1768906155299388
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
52020849
Annuals > 3 > income Statement > income Tax Expense
9000
Annuals > 3 > income Statement > EBITDA
-9174000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
5898000
Annuals > 3 > balance Sheet > cash
276776000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
48000
Annuals > 3 > balance Sheet > inventories
3008000
Annuals > 3 > balance Sheet > total Current Assets
279842000
Annuals > 3 > balance Sheet > property Plant Equipment
82000
Annuals > 3 > balance Sheet > total Assets
279924000
Annuals > 3 > balance Sheet > payables
883000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2749000
Annuals > 3 > balance Sheet > equity
277175000
Annuals > 3 > cash Flow > net Income
-9202000
Annuals > 3 > cash Flow > depreciation
19000
Annuals > 3 > cash Flow > change In Working Capital
-559000
Annuals > 3 > cash Flow > cash From Operations
-15283000
Annuals > 3 > cash Flow > capital Expenditures
104000
Annuals > 3 > cash Flow > cash From Investing
-104000
Annuals > 3 > cash Flow > cash From Financing
286447000
Annuals > 3 > cash Flow > net Change In Cash
270881000
Annuals > 3 > ratios > PE
-0.1768906155299388
Annuals > 3 > ratios > PB
2.845264078073419
Annuals > 3 > ratios > ROE
-3.319924235591233
Annuals > 3 > ratios > ROA
-3.287320844229148
Annuals > 3 > ratios > FCF
-15387000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.22602187237196172
Valuation > metrics > PB
2.77474772844264
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-4.81130553849216
Profitability > metrics > ROA
-4.7559279487092505
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.03646228341403652
Risk > metrics > Interest Coverage
-787.3809523809524
Risk > final Score
-3090
Risk > verdict
High
Liquidity > metrics > Current Ratio
70.15468824369349
Liquidity > metrics > Quick Ratio
70.15468824369349
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
42.102091071019444
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-278
Prev Risks > 1
-226
Prev Risks > 2
-229
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:32:51.080Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.2713
Earnings History > 0 > eps Difference
0.2713
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.23
Earnings History > 1 > eps Estimate
-0.235
Earnings History > 1 > eps Difference
0.005
Earnings History > 1 > surprise Percent
2.1277
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.15
Earnings History > 2 > eps Estimate
-0.21
Earnings History > 2 > eps Difference
0.06
Earnings History > 2 > surprise Percent
28.5714
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-08
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.19
Earnings History > 3 > eps Estimate
-0.35
Earnings History > 3 > eps Difference
0.16
Earnings History > 3 > surprise Percent
45.7143
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.17
Earnings History > 4 > eps Estimate
-0.2217
Earnings History > 4 > eps Difference
0.0517
Earnings History > 4 > surprise Percent
23.3198
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-14
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.23
Earnings History > 5 > eps Estimate
-0.24
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
4.1667
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-09-03
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2
Earnings History > 6 > eps Estimate
-0.22
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
9.0909
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-03
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.15
Earnings History > 7 > eps Estimate
-0.22
Earnings History > 7 > eps Difference
0.07
Earnings History > 7 > surprise Percent
31.8182
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-29
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.21
Earnings History > 8 > eps Estimate
-0.2
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-5
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.11
Earnings History > 9 > eps Estimate
-0.2
Earnings History > 9 > eps Difference
0.09
Earnings History > 9 > surprise Percent
45
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-23
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.15
Earnings History > 10 > eps Estimate
-0.25
Earnings History > 10 > eps Difference
0.1
Earnings History > 10 > surprise Percent
40
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.21
Earnings History > 11 > eps Estimate
-0.22
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
4.5455
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-02
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.32
Earnings History > 12 > eps Estimate
-0.17
Earnings History > 12 > eps Difference
-0.15
Earnings History > 12 > surprise Percent
-88.2353
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
-0.16
Earnings History > 13 > eps Difference
0.15
Earnings History > 13 > surprise Percent
93.75
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-23
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.01
Earnings History > 14 > eps Estimate
-0.17
Earnings History > 14 > eps Difference
0.18
Earnings History > 14 > surprise Percent
105.8824
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-18
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.11
Earnings History > 15 > eps Estimate
-0.16
Earnings History > 15 > eps Difference
0.05
Earnings History > 15 > surprise Percent
31.25
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.09
Earnings History > 16 > eps Estimate
-0.17
Earnings History > 16 > eps Difference
0.08
Earnings History > 16 > surprise Percent
47.0588
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-12-06
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.04
Earnings History > 17 > eps Estimate
-0.1
Earnings History > 17 > eps Difference
0.06
Earnings History > 17 > surprise Percent
60
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-23
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.05
Earnings History > 18 > eps Estimate
-0.08
Earnings History > 18 > eps Difference
0.03
Earnings History > 18 > surprise Percent
37.5
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-28
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.01
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0151
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0151
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0003
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0003
Earnings History > 21 > surprise Percent
-
GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWe Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - simplywall.st
12/11/2025
We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth simplywall.st
Read more →Stempoint Capital LP Acquires New Stake in GH Research PLC $GHRS MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$30.375
Analyst Picks
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 68.33% of the total shares of GH Research PLC
1.
Bvf Inc(14.2315%)
since
2025/06/30
2.
RA Capital Management, LLC(12.3759%)
since
2025/06/30
3.
RTW INVESTMENTS, LLC(8.932%)
since
2025/06/30
4.
FMR Inc(8.2092%)
since
2025/06/30
5.
Fidelity Growth Compy Commingled Pl S(4.1138%)
since
2025/07/31
6.
Cormorant Asset Management, LLC(3.2396%)
since
2025/06/30
7.
Deep Track Capital, LP(3.2243%)
since
2025/06/30
8.
The Toronto-Dominion Bank(3.1715%)
since
2025/06/30
9.
Fidelity Growth Company Fund(2.5246%)
since
2025/07/31
10.
Jefferies Financial Group Inc(1.1435%)
since
2025/06/30
11.
Verition Fund Managegment, LLC(1.0598%)
since
2025/06/30
12.
5AM Venture Management, LLC(0.9232%)
since
2025/06/30
13.
Fidelity Growth Company K6(0.901%)
since
2025/07/31
14.
UBS Group AG(0.7393%)
since
2025/06/30
15.
Fidelity Series Growth Company(0.6787%)
since
2025/07/31
16.
Fidelity Select Biotechnology(0.5478%)
since
2025/07/31
17.
Morgan Stanley - Brokerage Accounts(0.453%)
since
2025/06/30
18.
Alyeska Investment Group, L.P.(0.4111%)
since
2025/06/30
19.
Millennium Management LLC(0.3283%)
since
2025/06/30
20.
StemPoint Capital LP(0.1625%)
since
2025/06/30
21.
Morgan Stanley Inst Inception I(0.1202%)
since
2025/06/30
22.
Morgan Stanley Inception(0.1202%)
since
2025/06/30
23.
BlackRock Inc(0.1044%)
since
2025/06/30
24.
AdvisorShares Psychedelics ETF(0.0879%)
since
2025/08/29
25.
HighVista Strategies LLC(0.0842%)
since
2025/06/30
26.
EQ/Morgan Stanley Small Cap Growth K(0.0787%)
since
2025/07/31
27.
Northern Trust Corp(0.0628%)
since
2025/06/30
28.
AdvisorShares Investments, LLC(0.0617%)
since
2025/06/30
29.
iShares MSCI Ireland ETF(0.059%)
since
2025/08/31
30.
Fidelity Nasdaq Composite Index(0.0575%)
since
2025/07/31
31.
Geode Capital Management, LLC(0.0558%)
since
2025/06/30
32.
A4Investments SICAV SIF ACCI IlanaA2EURH(0.0161%)
since
2025/08/31
33.
Virtus LifeSci Biotech Clinical Trls ETF(0.0154%)
since
2025/08/29
34.
SPDR® S&P® International Small Cap ETF(0.0149%)
since
2025/08/29
35.
Northern Small Cap Core I(0.0113%)
since
2025/06/30
36.
NT Quality SCC US Fund - L(0.0057%)
since
2025/06/30
37.
NT Quality Small Cap Core(0.0057%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.2713
Date
2025-09-30
EPS Actual
-0.23
EPS Estimate
-0.235
EPS Difference
0.005
Surprise Percent
2.1277%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.